ADVOCACY SECTION

ILADS Guidelines Authors Defend Their Conclusion that Scientific Evidence from Lyme Clinical Trials is “Weak”

2020 FALL ADVOCACY

ILADS Guidelines Authors Defend Their Conclusion that Scientific Evidence from Lyme Clinical Trials is “Weak”

IDSA overstates the quality of the evidence it uses to deny care to chronically ill patients who fail standard treatment.

By Lorraine Johnson, JD, MBA

Sharing Alex’s Lyme Legacy with the Girl Scouts

2020 FALL ADVOCACY

Sharing Alex’s Lyme Legacy with the Girl Scouts

Project Tick aims to teach young girls about tick removal and Lyme disease prevention.

By Dorothy Kupcha Leland